SrasV1, PubMed, Checkpoint, bibRecord, 001B19

Human immunopathogenesis of severe acute respiratory syndrome (SARS).

Identifieur interne : 001B19 ( PubMed/Checkpoint ); précédent : 001B18; suivant : 001B20

Human immunopathogenesis of severe acute respiratory syndrome (SARS).

Auteurs : Mark J. Cameron [Canada] ; Jesus F. Bermejo-Martin ; Ali Danesh ; Matthew P. Muller ; David J. Kelvin

Source :

Virus research [ 0168-1702 ] ; 2008.

RBID : pubmed:17374415

Descripteurs français

KwdFr :
- Cytokines (immunologie), Cytokines (métabolisme), Humains, Immunité innée, Interactions hôte-pathogène, Modèles biologiques, Syndrome respiratoire aigu sévère (anatomopathologie), Syndrome respiratoire aigu sévère (génétique), Syndrome respiratoire aigu sévère (immunologie), Séquençage par oligonucléotides en batterie, Virus du SRAS (immunologie).
MESH :
- anatomopathologie : Syndrome respiratoire aigu sévère.
- génétique : Syndrome respiratoire aigu sévère.
- immunologie : Cytokines, Syndrome respiratoire aigu sévère, Virus du SRAS.
- métabolisme : Cytokines.
- Humains, Immunité innée, Interactions hôte-pathogène, Modèles biologiques, Séquençage par oligonucléotides en batterie.

English descriptors

KwdEn :
- Cytokines (immunology), Cytokines (metabolism), Host-Pathogen Interactions, Humans, Immunity, Innate, Models, Biological, Oligonucleotide Array Sequence Analysis, SARS Virus (immunology), Severe Acute Respiratory Syndrome (genetics), Severe Acute Respiratory Syndrome (immunology), Severe Acute Respiratory Syndrome (pathology).
MESH :
- chemical , immunology : Cytokines.
- chemical , metabolism : Cytokines.
- genetics : Severe Acute Respiratory Syndrome.
- immunology : SARS Virus, Severe Acute Respiratory Syndrome.
- pathology : Severe Acute Respiratory Syndrome.
- Host-Pathogen Interactions, Humans, Immunity, Innate, Models, Biological, Oligonucleotide Array Sequence Analysis.

Abstract

Progressive immune-associated injury is a hallmark of severe acute respiratory syndrome (SARS). Viral evasion of innate immunity, hypercytokinemia and systemic immunopathology in the SARS coronavirus (SARS CoV) infected host have been suggested as possible mechanisms for the cause of severe pathology and morbidity in SARS patients. The molecular and cellular basis for how SARS CoV impacts the host immune system resulting in severe SARS, however, has not been elucidated. The variable clinical course of SARS may be the result of complex programs of host responses against the infectious agent. Therefore, the systematic analysis of innate and adaptive immune responses to SARS CoV is imperative in building as complete an immunological model as possible of host immunity and inflammatory responses during illness. Here we review recent advances in SARS immunopathogenesis research and present a summary of our findings regarding host responses in SARS patients. We contend that dysregulated type I and II interferon (IFN) responses during SARS may culminate in a failure of the switch from hyper-innate immunity to protective adaptive immune responses in the human host.

DOI: 10.1016/j.virusres.2007.02.014
PubMed: 17374415

Affiliations:

Canada

Links toward previous steps (curation, corpus...)

to stream PubMed, to step Corpus: 001E67
to stream PubMed, to step Curation: 001E67

Links to Exploration step

pubmed:17374415

Le document en format XML

<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Human immunopathogenesis of severe acute respiratory syndrome (SARS).</title>
<author><name sortKey="Cameron, Mark J" sort="Cameron, Mark J" uniqKey="Cameron M" first="Mark J" last="Cameron">Mark J. Cameron</name>
<affiliation wicri:level="1"><nlm:affiliation>University Health Network, MaRS Centre, 101 College Street, Toronto, Ontario M5G 1L7, Canada. mcameron@uhnres.utoronto.ca</nlm:affiliation>
<country xml:lang="fr">Canada</country>
<wicri:regionArea>University Health Network, MaRS Centre, 101 College Street, Toronto, Ontario M5G 1L7</wicri:regionArea>
<wicri:noRegion>Ontario M5G 1L7</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Bermejo Martin, Jesus F" sort="Bermejo Martin, Jesus F" uniqKey="Bermejo Martin J" first="Jesus F" last="Bermejo-Martin">Jesus F. Bermejo-Martin</name>
</author>
<author><name sortKey="Danesh, Ali" sort="Danesh, Ali" uniqKey="Danesh A" first="Ali" last="Danesh">Ali Danesh</name>
</author>
<author><name sortKey="Muller, Matthew P" sort="Muller, Matthew P" uniqKey="Muller M" first="Matthew P" last="Muller">Matthew P. Muller</name>
</author>
<author><name sortKey="Kelvin, David J" sort="Kelvin, David J" uniqKey="Kelvin D" first="David J" last="Kelvin">David J. Kelvin</name>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">PubMed</idno>
<date when="2008">2008</date>
<idno type="RBID">pubmed:17374415</idno>
<idno type="pmid">17374415</idno>
<idno type="doi">10.1016/j.virusres.2007.02.014</idno>
<idno type="wicri:Area/PubMed/Corpus">001E67</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">001E67</idno>
<idno type="wicri:Area/PubMed/Curation">001E67</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Curation">001E67</idno>
<idno type="wicri:Area/PubMed/Checkpoint">001B19</idno>
<idno type="wicri:explorRef" wicri:stream="Checkpoint" wicri:step="PubMed">001B19</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title xml:lang="en">Human immunopathogenesis of severe acute respiratory syndrome (SARS).</title>
<author><name sortKey="Cameron, Mark J" sort="Cameron, Mark J" uniqKey="Cameron M" first="Mark J" last="Cameron">Mark J. Cameron</name>
<affiliation wicri:level="1"><nlm:affiliation>University Health Network, MaRS Centre, 101 College Street, Toronto, Ontario M5G 1L7, Canada. mcameron@uhnres.utoronto.ca</nlm:affiliation>
<country xml:lang="fr">Canada</country>
<wicri:regionArea>University Health Network, MaRS Centre, 101 College Street, Toronto, Ontario M5G 1L7</wicri:regionArea>
<wicri:noRegion>Ontario M5G 1L7</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Bermejo Martin, Jesus F" sort="Bermejo Martin, Jesus F" uniqKey="Bermejo Martin J" first="Jesus F" last="Bermejo-Martin">Jesus F. Bermejo-Martin</name>
</author>
<author><name sortKey="Danesh, Ali" sort="Danesh, Ali" uniqKey="Danesh A" first="Ali" last="Danesh">Ali Danesh</name>
</author>
<author><name sortKey="Muller, Matthew P" sort="Muller, Matthew P" uniqKey="Muller M" first="Matthew P" last="Muller">Matthew P. Muller</name>
</author>
<author><name sortKey="Kelvin, David J" sort="Kelvin, David J" uniqKey="Kelvin D" first="David J" last="Kelvin">David J. Kelvin</name>
</author>
</analytic>
<series><title level="j">Virus research</title>
<idno type="ISSN">0168-1702</idno>
<imprint><date when="2008" type="published">2008</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Cytokines (immunology)</term>
<term>Cytokines (metabolism)</term>
<term>Host-Pathogen Interactions</term>
<term>Humans</term>
<term>Immunity, Innate</term>
<term>Models, Biological</term>
<term>Oligonucleotide Array Sequence Analysis</term>
<term>SARS Virus (immunology)</term>
<term>Severe Acute Respiratory Syndrome (genetics)</term>
<term>Severe Acute Respiratory Syndrome (immunology)</term>
<term>Severe Acute Respiratory Syndrome (pathology)</term>
</keywords>
<keywords scheme="KwdFr" xml:lang="fr"><term>Cytokines (immunologie)</term>
<term>Cytokines (métabolisme)</term>
<term>Humains</term>
<term>Immunité innée</term>
<term>Interactions hôte-pathogène</term>
<term>Modèles biologiques</term>
<term>Syndrome respiratoire aigu sévère (anatomopathologie)</term>
<term>Syndrome respiratoire aigu sévère (génétique)</term>
<term>Syndrome respiratoire aigu sévère (immunologie)</term>
<term>Séquençage par oligonucléotides en batterie</term>
<term>Virus du SRAS (immunologie)</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="immunology" xml:lang="en"><term>Cytokines</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="metabolism" xml:lang="en"><term>Cytokines</term>
</keywords>
<keywords scheme="MESH" qualifier="anatomopathologie" xml:lang="fr"><term>Syndrome respiratoire aigu sévère</term>
</keywords>
<keywords scheme="MESH" qualifier="genetics" xml:lang="en"><term>Severe Acute Respiratory Syndrome</term>
</keywords>
<keywords scheme="MESH" qualifier="génétique" xml:lang="fr"><term>Syndrome respiratoire aigu sévère</term>
</keywords>
<keywords scheme="MESH" qualifier="immunologie" xml:lang="fr"><term>Cytokines</term>
<term>Syndrome respiratoire aigu sévère</term>
<term>Virus du SRAS</term>
</keywords>
<keywords scheme="MESH" qualifier="immunology" xml:lang="en"><term>SARS Virus</term>
<term>Severe Acute Respiratory Syndrome</term>
</keywords>
<keywords scheme="MESH" qualifier="métabolisme" xml:lang="fr"><term>Cytokines</term>
</keywords>
<keywords scheme="MESH" qualifier="pathology" xml:lang="en"><term>Severe Acute Respiratory Syndrome</term>
</keywords>
<keywords scheme="MESH" xml:lang="en"><term>Host-Pathogen Interactions</term>
<term>Humans</term>
<term>Immunity, Innate</term>
<term>Models, Biological</term>
<term>Oligonucleotide Array Sequence Analysis</term>
</keywords>
<keywords scheme="MESH" xml:lang="fr"><term>Humains</term>
<term>Immunité innée</term>
<term>Interactions hôte-pathogène</term>
<term>Modèles biologiques</term>
<term>Séquençage par oligonucléotides en batterie</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
<front><div type="abstract" xml:lang="en">Progressive immune-associated injury is a hallmark of severe acute respiratory syndrome (SARS). Viral evasion of innate immunity, hypercytokinemia and systemic immunopathology in the SARS coronavirus (SARS CoV) infected host have been suggested as possible mechanisms for the cause of severe pathology and morbidity in SARS patients. The molecular and cellular basis for how SARS CoV impacts the host immune system resulting in severe SARS, however, has not been elucidated. The variable clinical course of SARS may be the result of complex programs of host responses against the infectious agent. Therefore, the systematic analysis of innate and adaptive immune responses to SARS CoV is imperative in building as complete an immunological model as possible of host immunity and inflammatory responses during illness. Here we review recent advances in SARS immunopathogenesis research and present a summary of our findings regarding host responses in SARS patients. We contend that dysregulated type I and II interferon (IFN) responses during SARS may culminate in a failure of the switch from hyper-innate immunity to protective adaptive immune responses in the human host.</div>
</front>
</TEI>
<pubmed><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">17374415</PMID>
<DateCompleted><Year>2008</Year>
<Month>06</Month>
<Day>17</Day>
</DateCompleted>
<DateRevised><Year>2020</Year>
<Month>04</Month>
<Day>07</Day>
</DateRevised>
<Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Print">0168-1702</ISSN>
<JournalIssue CitedMedium="Print"><Volume>133</Volume>
<Issue>1</Issue>
<PubDate><Year>2008</Year>
<Month>Apr</Month>
</PubDate>
</JournalIssue>
<Title>Virus research</Title>
<ISOAbbreviation>Virus Res.</ISOAbbreviation>
</Journal>
<ArticleTitle>Human immunopathogenesis of severe acute respiratory syndrome (SARS).</ArticleTitle>
<Pagination><MedlinePgn>13-9</MedlinePgn>
</Pagination>
<Abstract><AbstractText>Progressive immune-associated injury is a hallmark of severe acute respiratory syndrome (SARS). Viral evasion of innate immunity, hypercytokinemia and systemic immunopathology in the SARS coronavirus (SARS CoV) infected host have been suggested as possible mechanisms for the cause of severe pathology and morbidity in SARS patients. The molecular and cellular basis for how SARS CoV impacts the host immune system resulting in severe SARS, however, has not been elucidated. The variable clinical course of SARS may be the result of complex programs of host responses against the infectious agent. Therefore, the systematic analysis of innate and adaptive immune responses to SARS CoV is imperative in building as complete an immunological model as possible of host immunity and inflammatory responses during illness. Here we review recent advances in SARS immunopathogenesis research and present a summary of our findings regarding host responses in SARS patients. We contend that dysregulated type I and II interferon (IFN) responses during SARS may culminate in a failure of the switch from hyper-innate immunity to protective adaptive immune responses in the human host.</AbstractText>
</Abstract>
<AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Cameron</LastName>
<ForeName>Mark J</ForeName>
<Initials>MJ</Initials>
<AffiliationInfo><Affiliation>University Health Network, MaRS Centre, 101 College Street, Toronto, Ontario M5G 1L7, Canada. mcameron@uhnres.utoronto.ca</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Bermejo-Martin</LastName>
<ForeName>Jesus F</ForeName>
<Initials>JF</Initials>
</Author>
<Author ValidYN="Y"><LastName>Danesh</LastName>
<ForeName>Ali</ForeName>
<Initials>A</Initials>
</Author>
<Author ValidYN="Y"><LastName>Muller</LastName>
<ForeName>Matthew P</ForeName>
<Initials>MP</Initials>
</Author>
<Author ValidYN="Y"><LastName>Kelvin</LastName>
<ForeName>David J</ForeName>
<Initials>DJ</Initials>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType>
<PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType>
</PublicationTypeList>
<ArticleDate DateType="Electronic"><Year>2007</Year>
<Month>03</Month>
<Day>19</Day>
</ArticleDate>
</Article>
<MedlineJournalInfo><Country>Netherlands</Country>
<MedlineTA>Virus Res</MedlineTA>
<NlmUniqueID>8410979</NlmUniqueID>
<ISSNLinking>0168-1702</ISSNLinking>
</MedlineJournalInfo>
<ChemicalList><Chemical><RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D016207">Cytokines</NameOfSubstance>
</Chemical>
</ChemicalList>
<CitationSubset>IM</CitationSubset>
<MeshHeadingList><MeshHeading><DescriptorName UI="D016207" MajorTopicYN="N">Cytokines</DescriptorName>
<QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName>
<QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D054884" MajorTopicYN="N">Host-Pathogen Interactions</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D007113" MajorTopicYN="N">Immunity, Innate</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D008954" MajorTopicYN="N">Models, Biological</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D020411" MajorTopicYN="N">Oligonucleotide Array Sequence Analysis</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D045473" MajorTopicYN="N">SARS Virus</DescriptorName>
<QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D045169" MajorTopicYN="N">Severe Acute Respiratory Syndrome</DescriptorName>
<QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName>
<QualifierName UI="Q000276" MajorTopicYN="Y">immunology</QualifierName>
<QualifierName UI="Q000473" MajorTopicYN="Y">pathology</QualifierName>
</MeshHeading>
</MeshHeadingList>
</MedlineCitation>
<PubmedData><History><PubMedPubDate PubStatus="received"><Year>2006</Year>
<Month>11</Month>
<Day>28</Day>
</PubMedPubDate>
<PubMedPubDate PubStatus="revised"><Year>2007</Year>
<Month>02</Month>
<Day>12</Day>
</PubMedPubDate>
<PubMedPubDate PubStatus="accepted"><Year>2007</Year>
<Month>02</Month>
<Day>19</Day>
</PubMedPubDate>
<PubMedPubDate PubStatus="pubmed"><Year>2007</Year>
<Month>3</Month>
<Day>22</Day>
<Hour>9</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="medline"><Year>2008</Year>
<Month>6</Month>
<Day>18</Day>
<Hour>9</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="entrez"><Year>2007</Year>
<Month>3</Month>
<Day>22</Day>
<Hour>9</Hour>
<Minute>0</Minute>
</PubMedPubDate>
</History>
<PublicationStatus>ppublish</PublicationStatus>
<ArticleIdList><ArticleId IdType="pubmed">17374415</ArticleId>
<ArticleId IdType="pii">S0168-1702(07)00054-8</ArticleId>
<ArticleId IdType="doi">10.1016/j.virusres.2007.02.014</ArticleId>
<ArticleId IdType="pmc">PMC7114310</ArticleId>
</ArticleIdList>
<ReferenceList><Reference><Citation>J Med Virol. 2005 Feb;75(2):185-94</Citation>
<ArticleIdList><ArticleId IdType="pubmed">15602737</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>J Leukoc Biol. 2001 Jun;69(6):912-20</Citation>
<ArticleIdList><ArticleId IdType="pubmed">11404376</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>Cell Microbiol. 2006 Jun;8(6):907-22</Citation>
<ArticleIdList><ArticleId IdType="pubmed">16681834</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>BMJ. 2003 Jun 21;326(7403):1354-8</Citation>
<ArticleIdList><ArticleId IdType="pubmed">12816820</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>J Pathol. 2004 Jun;203(2):631-7</Citation>
<ArticleIdList><ArticleId IdType="pubmed">15141377</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>JAMA. 2003 Jul 16;290(3):367-73</Citation>
<ArticleIdList><ArticleId IdType="pubmed">12865378</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>Cytokine. 2005 Jan 21;29(2):92-4</Citation>
<ArticleIdList><ArticleId IdType="pubmed">15598444</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>Lancet. 2003 May 24;361(9371):1773-8</Citation>
<ArticleIdList><ArticleId IdType="pubmed">12781536</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>Clin Exp Immunol. 2004 Apr;136(1):95-103</Citation>
<ArticleIdList><ArticleId IdType="pubmed">15030519</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>BMC Immunol. 2005 Jan 18;6:2</Citation>
<ArticleIdList><ArticleId IdType="pubmed">15655079</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>J Infect Dis. 2005 Jan 15;191(2):193-7</Citation>
<ArticleIdList><ArticleId IdType="pubmed">15609228</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>BMJ. 2003 Jun 21;326(7403):1358-62</Citation>
<ArticleIdList><ArticleId IdType="pubmed">12816821</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>Virology. 2005 Oct 10;341(1):163-9</Citation>
<ArticleIdList><ArticleId IdType="pubmed">16095648</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>Mod Pathol. 2005 Jan;18(1):1-10</Citation>
<ArticleIdList><ArticleId IdType="pubmed">15272286</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>Am J Respir Crit Care Med. 2005 Apr 15;171(8):850-7</Citation>
<ArticleIdList><ArticleId IdType="pubmed">15657466</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>JAMA. 2003 Jun 4;289(21):2801-9</Citation>
<ArticleIdList><ArticleId IdType="pubmed">12734147</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>PLoS Med. 2006 Sep;3(9):e343</Citation>
<ArticleIdList><ArticleId IdType="pubmed">16968120</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>N Engl J Med. 2003 May 15;348(20):1986-94</Citation>
<ArticleIdList><ArticleId IdType="pubmed">12682352</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>Lancet. 2003 May 24;361(9371):1767-72</Citation>
<ArticleIdList><ArticleId IdType="pubmed">12781535</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>Respirology. 2006 Nov;11(6):715-22</Citation>
<ArticleIdList><ArticleId IdType="pubmed">17052299</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>J Interferon Cytokine Res. 2004 Aug;24(8):439-54</Citation>
<ArticleIdList><ArticleId IdType="pubmed">15320958</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>Nature. 2003 Nov 27;426(6965):450-4</Citation>
<ArticleIdList><ArticleId IdType="pubmed">14647384</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>Radiology. 2003 Aug;228(2):395-400</Citation>
<ArticleIdList><ArticleId IdType="pubmed">12738877</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>J Virol. 2005 Jun;79(12):7819-26</Citation>
<ArticleIdList><ArticleId IdType="pubmed">15919935</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>J Immunol. 2004 Dec 1;173(11):6858-63</Citation>
<ArticleIdList><ArticleId IdType="pubmed">15557180</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>Clin Infect Dis. 2004 May 15;38(10):1420-7</Citation>
<ArticleIdList><ArticleId IdType="pubmed">15156481</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>J Pathol. 2004 Jun;203(2):622-30</Citation>
<ArticleIdList><ArticleId IdType="pubmed">15141376</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>Med J Aust. 2003 Jun 2;178(11):555-8</Citation>
<ArticleIdList><ArticleId IdType="pubmed">12765503</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>Radiology. 2003 Aug;228(2):401-6</Citation>
<ArticleIdList><ArticleId IdType="pubmed">12759474</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>Eur J Clin Microbiol Infect Dis. 2006 Apr;25(4):230-7</Citation>
<ArticleIdList><ArticleId IdType="pubmed">16586072</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>Clin Chem. 2005 Dec;51(12):2333-40</Citation>
<ArticleIdList><ArticleId IdType="pubmed">16195357</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>Curr Opin Immunol. 2005 Aug;17(4):404-10</Citation>
<ArticleIdList><ArticleId IdType="pubmed">15950449</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>JAMA. 2003 Jul 16;290(3):374-80</Citation>
<ArticleIdList><ArticleId IdType="pubmed">12865379</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>Radiology. 2005 Dec;237(3):1081-90</Citation>
<ArticleIdList><ArticleId IdType="pubmed">16304120</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>Nature. 2006 Jan 26;439(7075):382-3</Citation>
<ArticleIdList><ArticleId IdType="pubmed">16437080</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>World J Gastroenterol. 2005 Aug 28;11(32):5037-43</Citation>
<ArticleIdList><ArticleId IdType="pubmed">16124062</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>J Virol. 2005 Nov;79(21):13800-5</Citation>
<ArticleIdList><ArticleId IdType="pubmed">16227300</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>Nat Med. 2005 Aug;11(8):875-9</Citation>
<ArticleIdList><ArticleId IdType="pubmed">16007097</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>BMC Genomics. 2005 Sep 21;6:132</Citation>
<ArticleIdList><ArticleId IdType="pubmed">16174304</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
</PubmedData>
</pubmed>
<affiliations><list><country><li>Canada</li>
</country>
</list>
<tree><noCountry><name sortKey="Bermejo Martin, Jesus F" sort="Bermejo Martin, Jesus F" uniqKey="Bermejo Martin J" first="Jesus F" last="Bermejo-Martin">Jesus F. Bermejo-Martin</name>
<name sortKey="Danesh, Ali" sort="Danesh, Ali" uniqKey="Danesh A" first="Ali" last="Danesh">Ali Danesh</name>
<name sortKey="Kelvin, David J" sort="Kelvin, David J" uniqKey="Kelvin D" first="David J" last="Kelvin">David J. Kelvin</name>
<name sortKey="Muller, Matthew P" sort="Muller, Matthew P" uniqKey="Muller M" first="Matthew P" last="Muller">Matthew P. Muller</name>
</noCountry>
<country name="Canada"><noRegion><name sortKey="Cameron, Mark J" sort="Cameron, Mark J" uniqKey="Cameron M" first="Mark J" last="Cameron">Mark J. Cameron</name>
</noRegion>
</country>
</tree>
</affiliations>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Sante/explor/SrasV1/Data/PubMed/Checkpoint

HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 001B19 | SxmlIndent | more

HfdSelect -h $EXPLOR_AREA/Data/PubMed/Checkpoint/biblio.hfd -nk 001B19 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Sante
   |area=    SrasV1
   |flux=    PubMed
   |étape=   Checkpoint
   |type=    RBID
   |clé=     pubmed:17374415
   |texte=   Human immunopathogenesis of severe acute respiratory syndrome (SARS).
}}

Pour générer des pages wiki

HfdIndexSelect -h $EXPLOR_AREA/Data/PubMed/Checkpoint/RBID.i   -Sk "pubmed:17374415" \
       | HfdSelect -Kh $EXPLOR_AREA/Data/PubMed/Checkpoint/biblio.hfd   \
       | NlmPubMed2Wicri -a SrasV1

This area was generated with Dilib version V0.6.33.
Data generation: Tue Apr 28 14:49:16 2020. Site generation: Sat Mar 27 22:06:49 2021

	Serveur d'exploration SRAS
	Attention, ce site est en cours de développement ! Attention, site généré par des moyens informatiques à partir de corpus bruts. Les informations ne sont donc pas validées.

Serveur d'exploration SRAS

Human immunopathogenesis of severe acute respiratory syndrome (SARS).

Human immunopathogenesis of severe acute respiratory syndrome (SARS).

Source :

Descripteurs français

English descriptors

Abstract

Links toward previous steps (curation, corpus...)

Links to Exploration step

Le document en format XML

Pour manipuler ce document sous Unix (Dilib)

Pour mettre un lien sur cette page dans le réseau Wicri

Pour générer des pages wiki